Filtered By:
Condition: Hemorrhagic Stroke
Education: Academia

This page shows you your search results in order of relevance. This is page number 7.

Order by Relevance | Date

Total 250 results found since Jan 2013.

Drip-and-Ship Model for Thrombectomy in Stroke Patients with Large-Vessel Occlusion
Conclusions: The “drip-and-ship” model has the potential to be a feasible model for patients with LVO in the anterior circulation to undergo endovascular treatment. Further large-scale prospective studies are warranted to confirm these findings.Eur Neurol
Source: European Neurology - March 5, 2021 Category: Neurology Source Type: research

Sex-dependent association analysis between serum uric acid and spontaneous hemorrhagic transformation in patients with ischemic stroke
ConclusionsHigher serum UA was independently associated with a higher occurrence of spontaneous HT in male patients who were admitted within 24 h after the stroke onset without receiving reperfusion therapy.
Source: Frontiers in Neurology - March 3, 2023 Category: Neurology Source Type: research

Does Preexisting Antiplatelet Treatment Influence Postthrombolysis Intracranial Hemorrhage in Community‐treated Ischemic Stroke Patients? An Observational Study
ConclusionsThe authors did not find that preexisting antiplatelet use was associated with postthrombolysis ICH or sICH in this cohort of community treated patients. Preexisting tobacco use, younger age, and lower severity were associated with lower odds of sICH. The meta‐analyses demonstrated small, but statistically significant increases in the absolute risk of radiographic ICH and sICH, along with increased odds of sICH in patients with preexisting antiplatelet use. Resumen ¿Influye el Tratamiento Antiagregante Previo en la Hemorragia Intracraneal tras la Trombolisis en los Pacientes con Ictus Isquémicos Tratados en...
Source: Academic Emergency Medicine - February 13, 2013 Category: Emergency Medicine Authors: William J. Meurer, Heemun Kwok, Lesli E. Skolarus, Eric E. Adelman, Allison M. Kade, Jack Kalbfleisch, Shirley M. Frederiksen, Phillip A. Scott Tags: Original Research Contribution Source Type: research

Hemorrhagic and Ischemic Stroke: Medical, Imaging, Surgical, and Interventional Approaches, 1st Edition
Hemorrhagic and Ischemic Stroke by Bendok et al is an evidence-based, multispecialty review of stroke that will transform the radiologist into a more relevant part of the clinical team. The most striking feature of this book is how thoroughly the authors cite the literature to support the content. Where appropriate, they also refer to management decisions at their institutions. The radiologist who opens this book will find an organized text with superb illustrations that seamlessly blend with the text to improve retention of the material.
Source: Academic Radiology - March 7, 2013 Category: Radiology Authors: Nicholas Bodmer Tags: The Bookshelf Source Type: research

Endovascular recanalization of complete subacute to chronic atherosclerotic occlusions of intracranial arteries
Conclusions Endovascular recanalization can be performed with an acceptable safety profile in selected patients with symptomatic complete subacute to chronic intracranial atherosclerotic occlusion. Additional studies are warranted to investigate whether this treatment compares favorably with best medical management.
Source: Journal of NeuroInterventional Surgery - October 7, 2014 Category: Neurosurgery Authors: Aghaebrahim, A., Jovin, T., Jadhav, A. P., Noorian, A., Gupta, R., Nogueira, R. G. Tags: Editor''s choice, Ischemic stroke Source Type: research

Thrombectomy Outcomes in Acute Ischemic Stroke due to Middle Cerebral Artery M2 Occlusion with Stent-Retriever, Aspiration, and MERCI: Multi-Center Experience (P5.251)
Conclusions:Thrombectomy for AIS patients with MCA M2 ELVO with Stent-retriever appears to be feasible with a significantly higher rate of recanalization, lower sICH rate, and favorable 90-day mRS when compared to Aspiration and MERCI.Disclosure: Dr. Atchaneeyasakul has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Yavagal has received personal compensation for activities with Medtronic and Guidepoint as a consultant. Dr. Bouslama has nothing to disclose. Dr. Haussen has nothing to disclose. Dr. Kenmuir has nothing to disclose. Dr. Jadhav has nothing to disclose. Dr. Jovin has received personal compensation f...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Atchaneeyasakul, K., Malik, A., Yavagal, D., Bouslama, M., Haussen, D., Kenmuir, C., Jadhav, A., Jovin, T., Nogueira, R. Tags: Acute Cerebrovascular Interventional Therapies Source Type: research

Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol
Conclusion: RIC in combination with recanalization therapies appears to add no clinical benefit to patients, but whether it is beneficial to those that are not candidates for recanalization therapies is still to be demonstrated. TRICS-9 has been developed to elucidate this issue.Clinical Trial Registration:ClinicalTrials.gov, identifier: NCT04400981.
Source: Frontiers in Neurology - November 3, 2021 Category: Neurology Source Type: research

Clinical risk predictors for cerebral hyperperfusion syndrome after carotid endarterectomy
Conclusions Independent, prospective monitoring of a large cohort of CEA cases identified a brief time interval between ischaemic symptoms and endarterectomy as the clearest risk factor for CHS.
Source: Journal of Neurology, Neurosurgery and Psychiatry - April 8, 2013 Category: Neurosurgery Authors: Maas, M. B., Kwolek, C. J., Hirsch, J. A., Jaff, M. R., Rordorf, G. A. Tags: Epilepsy and seizures, Headache (including migraine), Pain (neurology), Stroke, Hypertension, Ophthalmology, Ischaemic heart disease, Disability Neurosurgery Source Type: research

The Spot sign and Tranexamic acid On Preventing ICH growth – AUStralasia Trial (STOP‐AUST): Protocol of a phase II randomized, placebo‐controlled, double‐blind, multicenter trial
DiscussionThis is the first trial to evaluate the efficacy of tranexamic acid in intracerebral hemorrhage patients selected based on an imaging biomarker of high likelihood of hematoma growth. The trial is registered as NCT01702636.
Source: International Journal of Stroke - August 26, 2013 Category: Neurology Authors: Atte Meretoja, Leonid Churilov, Bruce C. V. Campbell, Richard I. Aviv, Nawaf Yassi, Christen Barras, Peter Mitchell, Bernard Yan, Harshal Nandurkar, Christopher Bladin, Tissa Wijeratne, Neil J. Spratt, Jim Jannes, Jonathan Sturm, Jayantha Rupasinghe, Jorg Tags: Protocols Source Type: research

Variability in Outcome After Elective Cerebral Aneurysm Repair in High-Volume Academic Medical Centers Clinical Sciences
Conclusions— There is notable interhospital heterogeneity in outcomes among even the largest volume unruptured intracranial aneurysm referral centers. Although further regionalization may be needed, mandatory participation in prospective, adjudicated registries will be necessary to reliably identify factors associated with superior outcomes.
Source: Stroke - April 28, 2014 Category: Neurology Authors: Zacharia, B. E., Bruce, S. S., Carpenter, A. M., Hickman, Z. L., Vaughan, K. A., Richards, C., Gold, W. E., Lu, J., Appelboom, G., Solomon, R. A., Connolly, E. S. Tags: Health policy and outcome research, Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Clinical Sciences Source Type: research

Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis Clinical Sciences
Conclusions— Admission hyperglycemia is a strong predictor of poor clinical outcome in patients with cerebral venous thrombosis.
Source: Stroke - January 25, 2016 Category: Neurology Authors: Zuurbier, S. M., Hiltunen, S., Tatlisumak, T., Peters, G. M., Silvis, S. M., Haapaniemi, E., Kruyt, N. D., Putaala, J., Coutinho, J. M. Tags: Epidemiology, Risk Factors, Thrombosis Clinical Sciences Source Type: research

Safety of Mechanical Thrombectomy for Acute Ischemic Stroke in Patients on Novel Oral Anticoagulants (P1.196)
Conclusion: Patients on NOAC undergoing mechanical thrombectomy show a trend towards increased sICH compared to the warfarin group. This may warrant larger studies of safety of mechanical thrombectomy in the presence of NOACs.Disclosure: Dr. Sharma has nothing to disclose. Dr. Atchaneeyasakul has nothing to disclose. Dr. Ziayee has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Guada has nothing to disclose. Dr. Khandelwal has nothing to disclose. Dr. Ramdas has nothing to disclose. Dr. Yavagal has received personal compensation for activities with Covidien/evV3 as a consultant and Steering Committee Member.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Sharma, P., Atchaneeyasakul, K., Ziayee, H., Malik, A., Guada, L., Khandelwal, P., Ramdas, K., Yavagal, D. Tags: Acute Endovascular Therapy: Outcomes and Safety Source Type: research

Noncontrast Computed Tomography Hypodensities Predict Poor Outcome in Intracerebral Hemorrhage Patients Clinical Sciences
Conclusions— The presence of noncontract CT hypodensities at baseline independently predicts poor outcome and comes as a useful and widely available addition to our ability to predict ICH patients’ clinical evolution.
Source: Stroke - September 25, 2016 Category: Neurology Authors: Boulouis, G., Morotti, A., Brouwers, H. B., Charidimou, A., Jessel, M. J., Auriel, E., Pontes-Neto, O., Ayres, A., Vashkevich, A., Schwab, K. M., Rosand, J., Viswanathan, A., Gurol, M. E., Greenberg, S. M., Goldstein, J. N. Tags: Computerized Tomography (CT), Prognosis, Mortality/Survival, Cerebrovascular Disease/Stroke, Intracranial Hemorrhage Clinical Sciences Source Type: research

Apolipoprotein A1 rs5070 A/G polymorphism with stroke subtypes in Taiwan
Conclusion Our findings suggested that genetic polymorphisms of ApoA1 rs5070 A/G may play a role in the susceptibility to LAA among male diabetic patients.
Source: Journal of the Chinese Medical Association - February 23, 2017 Category: Journals (General) Source Type: research

Use of Platelet Function Testing Before Pipeline Embolization Device Placement Clinical Sciences
Conclusions—Clopidogrel nonresponders experienced a significantly higher rate of thromboembolic complications when compared with clopidogrel responders. However, this risk seems to be mitigated in nonresponders who were switched to ticagrelor or received a clopidogrel boost within 24 hours pre-procedure.
Source: Stroke - April 24, 2017 Category: Neurology Authors: Nimer Adeeb, Christoph J. Griessenauer, Paul M. Foreman, Justin M. Moore, Hussain Shallwani, Rouzbeh Motiei-Langroudi, Abdulrahman Alturki, Adnan H. Siddiqui, Elad I. Levy, Mark R. Harrigan, Christopher S. Ogilvy, Ajith J. Thomas Tags: Treatment, Cerebral Aneurysm, Cerebrovascular Disease/Stroke, Cerebrovascular Procedures Original Contributions Source Type: research